GHRL and invasive breast carcinoma: The aim of this study was to investigate the protein expression of ghrelin and obestatin by immunohistochemical staining of tissue microarrays consisting of 197 invasive breast carcinomas from MBC patients and to assess if any of these peptides could be useful as markers of clinical outcome in this rare disease.